Literature DB >> 9003367

Studies of the membrane topology of the rat erythrocyte H+/lactate cotransporter (MCT1).

R C Poole1, C E Sansom, A P Halestrap.   

Abstract

1. Hydrophobicity analysis of the monocarboxylate/proton cotransporter MCT1 (lactate transporter) suggests a structure with 12 transmembrane (TM) segments, presumed to be alpha-helical. 2. A series of anti-peptide antibodies have been raised against regions of the MCT1 sequence, which each recognize a polypeptide of approx. 40 kDa in rat erythrocytes. The topology of rat MCT1 was investigated by studying the immunoreactive fragments derived from proteolytic digestion of the protein in intact rat erythrocytes and leaky membranes. 3. Reactivity with an anti-(C-terminus) antibody was prevented on treatment of leaky membranes, but not intact cells, with carboxypeptidase Y, indicating that the C-terminus of the protein is cytoplasmically disposed. 4. Treatment of intact cells in saline buffer with trypsin, chymotrypsin, bromelain and protease K (up to 1 mg/ml) resulted in no degradation of MCT1, indicating the absence of any large exposed extracellular loop. In a buffer of low ionic strength (containing sucrose), cleavage was observed with bromelain at an extracellular site, probably TM9/10.5. Treatment of leaky membranes with low (less than 100 micrograms/ml) concentrations of several proteases resulted in fragmentation of MCT1, reflecting cleavage at the cytoplasmic face of the membrane. These treatments generated N-terminal fragments of apparent molecular mass approx. 17-19 kDa that were resistant to further degradation. The epitopes for the TM6/7 and C-terminal antibodies were either lost from the membrane or destroyed under most of these conditions, indicating that these regions of the protein are located in the cytoplasm. 6. More detailed structural prediction analysis of MCT-related sequences was made assuming the constraints placed upon the possible arrangements by the experimental data outlined above. This analysis provided additional strong evidence for the 12-TM-segment model, with cytoplasmic N- and C-terminal ends and a large internal loop between TM6 and TM7. The predicted helices were assigned moments of hydrophobicity and residue substitution; for a number of TM segments this permitted the prediction of the sides of the helix that faced membrane lipid and the interior of the protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9003367      PMCID: PMC1218002          DOI: 10.1042/bj3200817

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  cDNA cloning of MEV, a mutant protein that facilitates cellular uptake of mevalonate, and identification of the point mutation responsible for its gain of function.

Authors:  C M Kim; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

2.  Identification and partial purification of the erythrocyte L-lactate transporter.

Authors:  R C Poole; A P Halestrap
Journal:  Biochem J       Date:  1992-05-01       Impact factor: 3.857

3.  Proteolytic cleavage of the anion transporter and its orientation in the membrane.

Authors:  M J Tanner
Journal:  Methods Enzymol       Date:  1989       Impact factor: 1.600

4.  Modeling alpha-helical transmembrane domains: the calculation and use of substitution tables for lipid-facing residues.

Authors:  D Donnelly; J P Overington; S V Ruffle; J H Nugent; T L Blundell
Journal:  Protein Sci       Date:  1993-01       Impact factor: 6.725

Review 5.  The 12-transmembrane helix transporters.

Authors:  P J Henderson
Journal:  Curr Opin Cell Biol       Date:  1993-08       Impact factor: 8.382

Review 6.  Computer-aided analyses of transport protein sequences: gleaning evidence concerning function, structure, biogenesis, and evolution.

Authors:  M H Saier
Journal:  Microbiol Rev       Date:  1994-03

Review 7.  Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins.

Authors:  S A Baldwin
Journal:  Biochim Biophys Acta       Date:  1993-06-08

Review 8.  Transport of lactate and other monocarboxylates across mammalian plasma membranes.

Authors:  R C Poole; A P Halestrap
Journal:  Am J Physiol       Date:  1993-04

9.  Molecular characterization of a membrane transporter for lactate, pyruvate, and other monocarboxylates: implications for the Cori cycle.

Authors:  C K Garcia; J L Goldstein; R K Pathak; R G Anderson; M S Brown
Journal:  Cell       Date:  1994-03-11       Impact factor: 41.582

10.  Asparagine-linked oligosaccharides are localized to single extracytosolic segments in multi-span membrane glycoproteins.

Authors:  C Landolt-Marticorena; R A Reithmeier
Journal:  Biochem J       Date:  1994-08-15       Impact factor: 3.857

View more
  39 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

2.  CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression.

Authors:  P Kirk; M C Wilson; C Heddle; M H Brown; A N Barclay; A P Halestrap
Journal:  EMBO J       Date:  2000-08-01       Impact factor: 11.598

3.  Dynamic imaging of free cytosolic ATP concentration during fuel sensing by rat hypothalamic neurones: evidence for ATP-independent control of ATP-sensitive K(+) channels.

Authors:  Edward K Ainscow; Shirin Mirshamsi; Teresa Tang; Michael L J Ashford; Guy A Rutter
Journal:  J Physiol       Date:  2002-10-15       Impact factor: 5.182

Review 4.  Role of monocarboxylate transporters in human cancers: state of the art.

Authors:  Céline Pinheiro; Adhemar Longatto-Filho; João Azevedo-Silva; Margarida Casal; Fernando C Schmitt; Fátima Baltazar
Journal:  J Bioenerg Biomembr       Date:  2012-02       Impact factor: 2.945

5.  C6ORF192 forms a unique evolutionary branch among solute carriers (SLC16, SLC17, and SLC18) and is abundantly expressed in several brain regions.

Authors:  Josefin A Jacobsson; Olga Stephansson; Robert Fredriksson
Journal:  J Mol Neurosci       Date:  2009-08-21       Impact factor: 3.444

6.  Development and utility of anti-PepT1 anti-peptide polyclonal antibodies.

Authors:  S K Basu; J Shen; K J Elbert; C T Okamoto; V H Lee; H von Grafenstein
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

Review 7.  The SLC16 gene family-from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond.

Authors:  Andrew P Halestrap; David Meredith
Journal:  Pflugers Arch       Date:  2003-05-09       Impact factor: 3.657

8.  Identification and characterization of a monocarboxylate transporter (MCT1) in pig and human colon: its potential to transport L-lactate as well as butyrate.

Authors:  A Ritzhaupt; I S Wood; A Ellis; K B Hosie; S P Shirazi-Beechey
Journal:  J Physiol       Date:  1998-12-15       Impact factor: 5.182

9.  Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle.

Authors:  Marieangela C Wilson; David Meredith; Chotirote Bunnun; Richard B Sessions; Andrew P Halestrap
Journal:  J Biol Chem       Date:  2009-05-27       Impact factor: 5.157

10.  AR-C155858 is a potent inhibitor of monocarboxylate transporters MCT1 and MCT2 that binds to an intracellular site involving transmembrane helices 7-10.

Authors:  Matthew J Ovens; Andrew J Davies; Marieangela C Wilson; Clare M Murray; Andrew P Halestrap
Journal:  Biochem J       Date:  2010-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.